UNS unilife corporation
Add to My Watchlist 0.00% ! 0.5¢

Next C.C., page-6

  1. dazdesb
    9 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    01/06/15
    11:01
    Post #: 15388059
    Tomorrow's cardio blockbusters: Inside 'the next big leap' in controlling cholesterol
    March 31, 2014 | By Damian Garde
    FierceBiotech

    Sanofi and Regeneron hit a similar mark in their first Phase III trial of alirocumab, which also topped Merck's small-molecule therapy, and the pair are planning to report 9 more late-stage trials in 2014, unveiling data on roughly 6,000 patients, according to Bill Sasiela, vice president of program direction at Regeneron. Sanofi and Regeneron expect to have long-term data ready by 2018.
    UNS Price at posting: 56.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Significant gold intercepts below Samat and Sorowar pits in resource drilling update
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 017 – RBA holds the toppings
right-arrow Created with Sketch.
NEWS Johns Lyng Group enters scheme implementation deed with PEP
right-arrow Created with Sketch.
VMM Colossus PFS Unlocks World-Class Project Economics and Positions Viridis for Global Leadership
right-arrow Created with Sketch.
CC9 Chariot to Acquire Majority Stake in a Nigerian Lithium Portfolio
right-arrow Created with Sketch.
HAR Maiden Drilling Program to Commence at Ibel South Gold Project
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.